| Literature DB >> 28186570 |
A Ficheux1, N Gayrard1, F Duranton1, C Guzman1, I Szwarc2, F Vetromile2, P Brunet3, M F Servel2, A Argilés1,2.
Abstract
Background: Recent randomized controlled trials suggest that sufficiently high convection post-dilutional haemodiafiltration (HC-HDF) improves survival in dialysis patients, consequently this technique is increasingly being adopted. However, when performing HC-HDF, rigorous control systems of the ultrafiltration setting are required. Assessing the global ultrafiltration coefficient of the dialysis system [GKD-UF; defined as ultrafiltration rate (QUF)/transmembrane pressure] or water permeability may be adapted to the present dialysis settings and be of value in clinics.Entities:
Keywords: haemodiafiltration; high convection volumes; GKD-UF-max
Mesh:
Substances:
Year: 2017 PMID: 28186570 PMCID: PMC5837204 DOI: 10.1093/ndt/gfw370
Source DB: PubMed Journal: Nephrol Dial Transplant ISSN: 0931-0509 Impact factor: 5.992
FIGURE 1Methods and results of KUF and GKD-UF-max determinations. (A and B) Schematics of the setting to determine KUF. (A) The in vitro setting proposed by the FDA [15, 16] to assess KUF for high-permeability dialyzers. It is an isolated ultrafiltration system (with no dialysate), where KUF is determined by the slope of QUF/TMP points (see C). (B) The in vivo setting presently used in clinics, which is closed with an ultrafiltration controller (balancing chambers). (C) QUF increases linearly with TMP in isolated ultrafiltration, the in vivo KUF of the dialyzer is the slope of this line (KUF = 1.414 × 60 = 85 mL/h/mmHg) (open squares). The straight line is shifted to the right and parallel when introducing a dialysate flow (same slope and therefore same KUF according to Keshaviah's calculations). The shift may be explained, at least in part, by the hydrostatic pressure linked to dialysate flow and the oncotic pressure modifications linked to blood flow. When measurements of QUF higher than those proposed by Keshaviah's were performed, the QUF–TMP relationship no longer followed a straight line function. It bent and tended to plateau. (D) Plotting the values of GKD-UF (QUF/TMP)/QUF for these in vivo measurements described the parabolic distribution of GKD-UF. The vertex of the parabola is GKD-UF-max and the corresponding QUF is the highest QUF that can be obtained for the minimal TMP.
FIGURE 2GKD-UF-max and QUF at GKD-UF-max reproducibility. (A) GKD-UF was consecutively determined three times at the initiation and just before the end of the dialysis session in three patients. The coefficient of variation (CV) was calculated for each patient and the mean ± SEM of individual CVs is plotted. It can be observed that coefficients of variation the CV was <3%. The variability of the measure of the value of GKD-UF-max decreased with the dialysis session, whereas the variability of the QUF at which GKD-UF-max is obtained was remarkably low at the beginning. (B) The points represent the mean of a minimum of four GKD-UF measures for 12 patients and the bars are the SEM. The measurements were performed at the beginning of the first session of the week during four consecutive weeks. The blood flow was 370 ± 33 mL/min (mean ± SD), with a range of 300–400 mL/min. It can be observed that the cross-patient variation may be important (>30%), while the values observed for a given patient are in a narrow range (small SEM lines).
Patient characteristics
| Characteristics | Patients ( |
|---|---|
| Sex ratio | 8 males/7 females |
| Age (years), mean ± SEM | 73 ± 12 |
| Body weight after dialysis (kg), mean ± SEM | 71 ± 2 |
| Serum proteins (g/L), mean ± SEM | 62.8 ± 1.2 |
| Haematocrit (%), mean ± SEM | 35.5 ± 1.4 |
| Haemoglobin (g/dL), mean ± SEM | 11.1 ± 0.3 |
| Initial renal disease, | |
| Diabetic nephropathy | 4 |
| Glomerulonephritis | 2 |
| Nephroangiosclerosis | 3 |
| Polycystic renal disease | 2 |
| Other/unknown | 4 |
| Vascular access, | |
| Native arterio-venous fistula | 14 |
| Jugular catheter | 1 |
| Blood flow (mL/min), mean ± SEM | 373 ± 8 |
FIGURE 3Mean GKD-UF-max variations during the treatment. (A) The influence of the dialysis technique and time on GKD-UF-max. The same patients were treated with either haemodialysis (HD) or HDF. GKD-UF was measured at the beginning of the treatment and at 60 and 180 min; HD and HDF are plotted. The absolute value of GKD-UF-max decreased during the treatment and, although not significantly different, there was a trend towards a greater decrease for HDF. (B) The influence of body weight loss on GKD-UF-max variation during dialysis. The change in GKD-UF-max (% difference of initial and 180 min) was significantly correlated with body weight loss] in percentage of total body weight; R2 = 0.65 (P < 0.001)], showing that patient factors (among which, probably refilling) influence the decrease of GKD-UF-max during the dialysis session.
FIGURE 4Effect of blood flow and infusion site on GKD-UF. The upper panels display the measurements of GKD-UF in a patient treated with two different blood flows [Qb = 250 mL/min (full squares) and Qb = 400 mL/min (open diamonds)] and using two different infusion sites [post-dilution (left-hand side) and pre-dilution (right-hand side)]. The lower panels show the effect of increasing blood flow on GKD-UF-max and its associated QUF. Both significantly increased in post-dilution HDF (left-hand side), while they decreased in pre-dilution HDF(right-hand side) (N = 6 and P < 0.05 for all), although to a lesser extent.